Strongbridge Biopharma Plc Announces Pricing Of Public Offering Of Ordinary Shares

Strongbridge Biopharma plc, today announced that it has priced its previously announced underwritten public offering of 4,000,000 ordinary shares at a price to the public of $6.25 per share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.